Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly operating income is $7.17B with a quarterly period change of +12.18%. Operating income measures profit from core operations before interest and taxes.
Reported quarterly operating income; no daily interpolation.
Operating Income growth vs the same quarter one year earlier, last 40 quarters.
| Period | Operating Income | % Change |
|---|---|---|
| Quarter ended Jun 2026 | $7.17B | +12.18% |
| Quarter ended Mar 2026 | $6.39B | +14.38% |
| Quarter ended Dec 2025 | $5.59B | (21.21%) |
| Quarter ended Sep 2025 | $7.10B | +4.20% |
| Quarter ended Jun 2025 | $6.81B | +8.11% |
| Quarter ended Mar 2025 | $6.30B | +63.99% |
| Quarter ended Dec 2024 | $3.84B | (27.23%) |
| Quarter ended Sep 2024 | $5.28B | (20.72%) |
| Quarter ended Jun 2024 | $6.66B | +6.12% |
| Quarter ended Mar 2024 | $6.27B | +36.16% |
| Quarter ended Dec 2023 | $4.61B | (25.67%) |
| Quarter ended Oct 2023 | $6.20B | (2.52%) |
| Quarter ended Jul 2023 | $6.36B | +1.79% |
| Quarter ended Apr 2023 | $6.25B | +59.95% |
| Quarter ended Dec 2022 | $3.90B | (31.06%) |
| Quarter ended Oct 2022 | $5.66B | (12.48%) |
| Quarter ended Jul 2022 | $6.47B | +5.79% |
| Quarter ended Apr 2022 | $6.12B | +36.72% |
| Quarter ended Dec 2021 | $4.47B | (34.82%) |
| Quarter ended Oct 2021 | $6.87B | +7.99% |
| Quarter ended Jul 2021 | $6.36B | (7.16%) |
| Quarter ended Apr 2021 | $6.85B | +64.14% |
| Quarter ended Dec 2020 | $4.17B | (29.75%) |
| Quarter ended Sep 2020 | $5.94B | +42.87% |
| Quarter ended Jun 2020 | $4.16B | (28.89%) |
| Quarter ended Mar 2020 | $5.85B | +34.64% |
| Quarter ended Dec 2019 | $4.34B | (26.27%) |
| Quarter ended Sep 2019 | $5.89B | +8.85% |
| Quarter ended Jun 2019 | $5.41B | +1.52% |
| Quarter ended Mar 2019 | $5.33B | +26.34% |
| Quarter ended Dec 2018 | $4.22B | (26.10%) |
| Quarter ended Sep 2018 | $5.71B | +3.39% |
| Quarter ended Jul 2018 | $5.52B | (3.61%) |
| Quarter ended Apr 2018 | $5.73B | +74.00% |
| Quarter ended Dec 2017 | $3.29B | (30.21%) |
| Quarter ended Oct 2017 | $4.72B | (12.78%) |
| Quarter ended Jul 2017 | $5.41B | (2.10%) |
| Quarter ended Apr 2017 | $5.52B | +19.49% |
| Quarter ended Dec 2016 | $4.62B | (14.13%) |
| Quarter ended Oct 2016 | $5.38B | (5.64%) |
| Quarter ended Jul 2016 | $5.71B | +4.66% |
| Quarter ended Apr 2016 | $5.45B | +61.16% |
| Quarter ended Dec 2015 | $3.38B | (27.14%) |
| Quarter ended Sep 2015 | $4.64B | (5.57%) |
| Quarter ended Jun 2015 | $4.92B | (8.02%) |
| Quarter ended Mar 2015 | $5.35B | +35.55% |
| Quarter ended Dec 2014 | $3.94B | (29.28%) |
| Quarter ended Sep 2014 | $5.58B | (6.58%) |
| Quarter ended Jun 2014 | $5.97B | +5.74% |
| Quarter ended Mar 2014 | $5.65B | +38.65% |
| Quarter ended Dec 2013 | $4.07B | (16.47%) |
| Quarter ended Sep 2013 | $4.88B | (3.77%) |
| Quarter ended Jun 2013 | $5.07B | +2.47% |
| Quarter ended Mar 2013 | $4.94B | +38.76% |
| Quarter ended Dec 2012 | $3.56B | (17.22%) |
| Quarter ended Sep 2012 | $4.30B | (6.46%) |
| Quarter ended Jul 2012 | $4.60B | +0.81% |
| Quarter ended Apr 2012 | $4.56B | +38.14% |
| Quarter ended Dec 2011 | $3.30B | (15.71%) |
| Quarter ended Oct 2011 | $3.92B | (9.43%) |
| Quarter ended Jul 2011 | $4.33B | (5.93%) |
| Quarter ended Apr 2011 | $4.60B | +33.67% |
| Quarter ended Dec 2010 | $3.44B | (14.42%) |
| Quarter ended Oct 2010 | $4.02B | (6.38%) |
| Quarter ended Jul 2010 | $4.30B | (9.88%) |
| Quarter ended Apr 2010 | $4.77B | +40.33% |
| Quarter ended Dec 2009 | $3.40B | (20.31%) |
| Quarter ended Sep 2009 | $4.26B | (2.09%) |
| Quarter ended Jun 2009 | $4.35B | (6.35%) |
| Quarter ended Mar 2009 | $4.65B | +53.08% |
| Quarter ended Dec 2008 | $3.04B | (25.76%) |
| Quarter ended Sep 2008 | $4.09B | (3.88%) |
| Quarter ended Jun 2008 | $4.26B | (10.31%) |
| Quarter ended Mar 2008 | $4.75B | +49.50% |
| Quarter ended Dec 2007 | $3.17B | (19.91%) |
| Quarter ended Sep 2007 | $3.96B | +2.19% |
| Quarter ended Jul 2007 | $3.88B | (7.62%) |
| Quarter ended Apr 2007 | $4.20B | +43.13% |
| Quarter ended Dec 2006 | $2.93B | (19.13%) |
| Quarter ended Oct 2006 | $3.63B | +6.80% |
| Quarter ended Jul 2006 | $3.40B | (9.51%) |
| Quarter ended Apr 2006 | $3.75B | +53.31% |
| Quarter ended Dec 2005 | $2.45B | (24.82%) |
| Quarter ended Oct 2005 | $3.26B | (5.27%) |
| Quarter ended Jul 2005 | $3.44B | (10.14%) |
| Quarter ended Apr 2005 | $3.83B | +43.58% |
| Quarter ended Dec 2004 | $2.66B | (19.61%) |
| Quarter ended Sep 2004 | $3.31B | (3.35%) |
| Quarter ended Jun 2004 | $3.43B | (0.81%) |
| Quarter ended Mar 2004 | $3.46B | +56.92% |
| Quarter ended Dec 2003 | $2.20B | (23.24%) |
| Quarter ended Sep 2003 | $2.87B | (0.62%) |
| Quarter ended Jun 2003 | $2.89B | (0.76%) |
| Quarter ended Mar 2003 | $2.91B | +44.49% |
| Quarter ended Dec 2002 | $2.01B | (19.76%) |
| Quarter ended Sep 2002 | $2.51B | N/A |